Device Trial Radar · NCT04581304
The Use of Bio-Oss Collagen for Sinus Augmentation Using the Transcrestal Approach.
Last checked: Nov 19, 2026Latest source record: Nov 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
36
Actual
Start
Oct 15, 2020
Primary completion
Dec 17, 2026
Study completion Jan 17, 2028
Sponsor
- Lead sponsor
- Rambam Health Care CampusAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 9, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To assess vertical bone height gain with Geistlich Bio-Oss Collagen used in conjunction with simultaneous implant installation in transcrestal approach sinus augmentation.
Conditions
- Bone Loss
- Missing Teeth
Interventions
Geistlich Bio-Oss® CollagenDevice
Geistlich Bio-Oss® Collagen is intended to be used for filling bone defects and for bone augmentation.
Geistlich Bio-Oss® GranulesDevice
Geistlich Bio-Oss® Granules is intended to be used for filling bone defects and for bone augmentation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Vertical bone height. (mm)Changes in augmented bone after transcrestal approach sinus augmentation.Time frame: Pre op; immediately post-op, at 6 months and 3 years from second stage surgery.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Rambam Health Care Campus, Dept. of Periodontology
Haifa, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.